Hyenergy S.A. (WQ3)
XFRA XFRA Primary Summary
Hyenergy S.A. (WQ3) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Hyenergy S.A. ever had a stock split?
Hyenergy S.A. Profile
| Professional Services Industry | Industrials Sector | Mr. Jacek Marek Wojciechowicz CEO | XFRA Exchange | PLINNGN00015 ISIN |
| Poland Country | 8 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Inno-Gene S.A. is a pioneering company based in Poznan, Poland, dedicated to providing state-of-the-art genetic diagnostic solutions since its establishment in 2010. With a strong focus on research and diagnostics, the company is at the forefront of implementing advanced technologies for DNA analysis. Inno-Gene S.A. is dedicated to enhancing the prevention and personalization of treatment for HPV-dependent solid tumors through the development and application of diagnostic algorithms. Leveraging the power of Next Generation Sequencing (NGS) technology, it offers comprehensive DNA analysis and genetic disease diagnostics, setting a new standard in the field of genomics in Poland.
Products and Services
- Research and Diagnostic Center Implementation
- Technologies in DNA Analysis
- Diagnostic Algorithm for HPV-Dependent Solid Tumors
- DNA Analysis and Genetic Diseases Diagnostic Service
This aspect of Inno-Gene S.A. focuses on the establishment and enhancement of research facilities and diagnostic centers. By integrating the latest in DNA analysis technologies, Inno-Gene ensures that institutions are equipped with cutting-edge tools and methodologies for genetic diagnostics and research.
Inno-Gene S.A. specializes in providing advanced technologies for DNA analysis, encompassing a wide range of applications from genetic disease diagnostics to forensic science. Their solutions are designed to meet the rigorous demands of modern genetics, ensuring precision and reliability in DNA sequencing and analysis.
One of the standout innovations of Inno-Gene S.A. is the development of a diagnostic algorithm aimed at enhancing the prevention and treatment personalization for HPV-dependent solid tumors. This pioneering approach contributes to more accurate diagnosis and tailored treatment plans, significantly improving patient outcomes.
Leveraging Next Generation Sequencing (NGS) technology, Inno-Gene offers comprehensive services for DNA analysis and the diagnosis of genetic diseases. This service utilizes the most advanced sequencing methods to provide accurate, high-resolution insights into the genetic underpinnings of various conditions, facilitating early diagnosis and personalized treatment strategies.
